IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · IEX Real-Time Price · USD
33.72
-2.20 (-6.12%)
At close: Jul 2, 2024, 4:00 PM
33.91
+0.19 (0.56%)
After-hours: Jul 2, 2024, 6:54 PM EDT
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 49.8, with a low estimate of 33 and a high estimate of 63. The average target predicts an increase of 47.69% from the current stock price of 33.72.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDYA stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 4 | 5 | 5 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $55 → $63 | Strong Buy | Maintains | $55 → $63 | +86.83% | Jun 4, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $53 → $46 | Strong Buy | Maintains | $53 → $46 | +36.42% | May 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $52 | Buy | Reiterates | $52 | +54.21% | May 8, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $60 | Strong Buy | Maintains | $40 → $60 | +77.94% | Mar 21, 2024 |
| BTIG | BTIG | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +63.11% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
13.60M
from 23.39M
Decreased by -41.86%
Revenue Next Year
17.74M
from 13.60M
Increased by 30.47%
EPS This Year
-2.36
from -1.96
EPS Next Year
-1.91
from -2.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.2M | 60.4M | 207.6M | 385.7M | 904.4M |
| Avg | 13.6M | 17.7M | 89.1M | 299.9M | 715.9M |
| Low | n/a | n/a | 17.2M | 194.7M | 460.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.8% | 343.9% | 1,070.1% | 333.0% | 201.6% |
| Avg | -41.9% | 30.5% | 402.1% | 236.7% | 138.7% |
| Low | - | - | -2.8% | 118.6% | 53.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.02 | 6.10 | -0.86 | 1.14 | 4.78 |
| Avg | -2.36 | -1.91 | -2.30 | -0.47 | 3.08 |
| Low | -2.57 | -3.12 | -3.22 | -2.41 | 1.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.